Director/PDMR Shareholding (8411E)
April 13 2011 - 7:07AM
UK Regulatory
TIDMHIK
RNS Number : 8411E
Hikma Pharmaceuticals Plc
13 April 2011
Annex DTR3
Notification of Transactions of Directors/Persons Discharging
Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital
letters.
State whether the notification
relates to (i) a transaction
notified in accordance with DTR
3.1.2 R, (ii) a disclosure made
in accordance LR 9.8.6R(1) or
(iii) a disclosure made in
accordance with section 793 of
Name of the issuer the Companies Act (2006). (i) &
1. HIKMA PHARMACEUTICALS PLC 2. (iii)
State whether notification
relates to a person connected
with a person discharging
Name of person discharging managerial
managerial responsibilities/director named
responsibilities/director in 3 and identify the connected
3. BASSAM KANAAN 4. person N/A
-------------------------------- ---- --------------------------------
Indicate whether the
notification is in respect of a Description of shares
holding of the person referred (including class), debentures
to in 3 or 4 above or in or derivatives or financial
respect of a nonbeneficial instruments relating to shares
5. interest 1 3 ABOVE 6. ORDINARY SHARES OF 10P EACH
-------------------------------- ---- --------------------------------
Name of registered State the nature of the
shareholders(s) and, if more transaction EXERCISE OF 256,418
than one, the number of shares ORDINARY SHARES AT $0.9075 PER
held by each of them BASSAM SHARE UNDER THE TERMS OF THE
7. KANAAN 8. 2004 STOCK OPTION PLAN
-------------------------------- ---- --------------------------------
Percentage of issued class
acquired (treasury shares of
Number of shares, debentures or that class should not be taken
financial instruments relating into account when calculating
9. to shares acquired N/A 10. percentage) N/A
-------------------------------- ---- --------------------------------
Percentage of issued class
disposed (treasury shares of
Number of shares, debentures or that class should not be taken
financial instruments relating into account when calculating
11. to shares disposed 20,072 12. percentage) 0.01%
-------------------------------- ---- --------------------------------
Price per share or value of
transaction 2,000 at GBP7.45p
on 8 April 2011and 18,072 at Date and place of transaction
13. GBP7.17p on 12 April 2011 14. 8 and 12 April 2011, LONDON
-------------------------------- ---- --------------------------------
Total holding following
notification and total
percentage holding following
notification (any treasury
shares should not be taken into
account when calculating Date issuer informed of
15. percentage) 325,568 (0.17%) 16. transaction 13 April 2011
-------------------------------- ---- --------------------------------
If a person discharging managerial responsibilities has been
granted options by the issuer
complete the following boxes
Period during which or date
Date of grant on which exercisable
17. N/A 18. N/A
Description of shares or
Total amount paid (if any) debentures involved (class
for grant of the option and number)
19. N/A 20. N/A
--------------------------- ---- -------------------------------
Exercise price (if fixed
at time of grant) or
indication that price is Total number of shares or
to be fixed at the time debentures over which options
of exercise held following notification
21. N/A 22. N/A
--------------------------- ---- -------------------------------
Name of contact and telephone
Any additional information number for queries
23. N/A 24. Peter Speirs 0207 399 2772
--------------------------- ---- -------------------------------
Name of authorised official of issuer responsible for making
notification
Henry Knowles
Date of notification 13 April 2011
Notes: This form is intended for use by an issuer to make a RIS
notification required by DR 3.3.
(1) An issuer making a notification in respect of a transaction
relating to the shares or debentures of the issuer
should complete boxes 1 to 16, 23 and 24.
(2) An issuer making a notification in respect of a derivative
relating the shares of the issuer should complete boxes
1 to 4, 6, 8, 13, 14, 16, 23 and 24.
(3) An issuer making a notification in respect of options
granted to a director/person discharging managerial
responsibilities should complete boxes 1 to 3 and 17
to 24.
(4) An issuer making a notification in respect of a financial
instrument relating to the shares of the issuer (other
than a debenture) should complete boxes 1 to 4, 6,
8, 9, 11, 13, 14, 16, 23 and 24.
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSBBGDSLGBBGBX
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024
